Ubenimex ( DrugBank: Ubenimex )

1 disease

ID	Disease name (Link within this page)	Number of trials
86	Pulmonary arterial hypertension	2

86. Pulmonary arterial hypertension

Clinical trials : 1,181 / Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02736149 (ClinicalTrials.gov)	December 2016	4/4/2016	Open-Label Extension Study of Ubenimexin Patients With Pulmonary Arterial Hypertension (WHO Group 1) ...	A Phase 2, Open-Label, Extension Study to Evaluate the Long-Term Safety and Efficacy of Ubenimexin P ...	Pulmonary Arterial Hypertension	Drug: ubenimex	Eiger BioPharmaceuticals	NULL	Terminated	18 Years	75 Years	All	51	Phase 2	United States;Canada
2	NCT02664558 (ClinicalTrials.gov)	April 2016	21/1/2016	A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)	A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimexin Patients With Pulmonary ...	Pulmonary Arterial Hypertension	Drug: ubenimex;Other: placebo	Eiger BioPharmaceuticals	NULL	Completed	18 Years	75 Years	All	61	Phase 2	United States;Canada

First Previous1Next Last